AI Is Going Nuclear: How Major Tech Companies Are Pursuing Nuclear Energy—And How Energy Startups Can Avoid Common Collaboration Pitfalls
Key Takeaways: As major technology companies turn to nuclear energy, early-stage nuclear companies may face heightened intellectual property (IP) risks due to asymmetric negotiations. Building and documenting strong background IP—and...
Three Knobbe Martens Partners Named Los Angeles Times “Life Sciences Visionaries”
IRVINE, Calif., April 20, 2026 – Knobbe Martens is pleased to share that partners Salima Merani, Ph.D., Jason Jardine, and Kimberly Miller, Ph.D. have been recognized as “Life Sciences Visionaries”...
FDA Issues Recommendations for the Development of Individualized Therapies for Patients With Ultra-Rare Diseases
Key Takeaway: The FDA is developing a “plausible mechanism framework” to facilitate approval of individualized therapies for the treatment of rare genetic diseases that currently face approval challenges. As discussed previously...